BTS
TNDM icon

BB&T Securities’s Tandem Diabetes Care TNDM Stock Holding History

BB&T Securities’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$235K Buy
4,007
+8
+0.2% +$511 ﹤0.01% 1430
2019
Q2 		$258K Buy
3,999
+33
+0.8% +$2.13K ﹤0.01% 1385
2019
Q1 		$251K Buy
+3,966
New +$208K ﹤0.01% 1389
2018
Q4 		– Sell
-7,683
Closed -$329K – 1607
2018
Q3 		$329K Buy
+7,683
New +$268K ﹤0.01% 1291

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BB&T Securities's TNDM Position: Q3 2019 in Review

BB&T Securities increased its Tandem Diabetes Care (TNDM) stake by 0.2% in Q3 2019, buying an estimated $511 and bringing the position to 4,007 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

BB&T Securities first reported a position in TNDM in Q3 2018 and has held it in 4 quarters since. The position peaked at $329K in Q3 2018. 273 funds tracked by Wall St. Rank hold TNDM as of Q3 2019.

  • BB&T Securities held 4,007 shares of Tandem Diabetes Care worth $235K as of Q3 2019.
  • BB&T Securities bought 8 Tandem Diabetes Care shares in Q3 2019, an estimated $511.
  • Tandem Diabetes Care made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1430 holding.
  • BB&T Securities first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 4 quarters since.
  • BB&T Securities's Tandem Diabetes Care position peaked at $329K in Q3 2018.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.